Advertisement

Search Results for "Tornier Inc"

22:07 EDT 21st May 2013 | BioPortfolio

Original Source: Tornier Inc.

Tornier is a global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company’s broad offering of over 80 product lines includes joint replacement, trauma, sports medicine, and biologic products to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 yea...

Matching Channels

None

Matching News

Award Recognizes Entrepreneurial Excellence in Healthcare Category

Award Recognizes Entrepreneurial Excellence in Healthcare Category MINNEAPOLIS--(BUSINESS WIRE)--Jun 20, 2012-- Tornier, Inc., the U.S. operating subsidiary of Tornier NV (NASDAQ: TRNX) announced th...

Tornier announces $68.5 million public offering financing

Tornier announced the pricing of a previously announced underwritten registered public offering financing of 7.0 million ordinary shares at a public offering price of $16.15 per ordinary share. The...

[Tornier NV] nets $68.5mm via FOPO

Orthopedic device maker [Tornier NV] netted $68.5mm in its follow-on public offering of 4.5mm ordinary shares at $16.15. Existing stockholders sold an additional 2.5mm shares.

[Tornier NV] nets $78.8mm via FOPO

Orthopedic device maker [Tornier NV] netted $78.8mm in its follow-on public offering of 5.2mm ordinary shares (including the overallotment) at $16.15. Existing stockholders sold an additional 2.5mm sh...

Tornier to Present at the 24th Annual Piper Jaffray Healthcare Conference

Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the C...

Tornier to Present at the 31st Annual J.P. Morgan Healthcare Conference

Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the C...

Tornier to Present at the 2013 RBC Capital Markets Global Healthcare Conference

Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the C...

Tornier to Present at the Credit Suisse 2012 Healthcare Conference

Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the C...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement